Related Experiment Video
Updated: Feb 22, 2026
06:43
Increased Recovery Time and Decreased LPS Administration to Study the Vagus Nerve Stimulation Mechanisms in Limited Inflammatory Responses
Published on: March 29, 2017
10.5K
The Medina Embolic Device: Karolinska experience
P Bhogal1,2, P A Brouwer1, L Yeo1,3
11 Department of Neuroradiology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Summary
The Medina Embolic Device (MED) shows promise for treating brain aneurysms, with multiple devices improving occlusion rates. However, single MED use is not recommended, and more research is needed.
Area of Science:
- Neurosurgery
- Interventional Radiology
- Vascular Neurology
Background:
- Cerebral aneurysms pose significant risks, necessitating effective treatment options.
- The Medina Embolic Device (MED) is an intra-saccular device designed for aneurysm treatment.
Purpose of the Study:
- To evaluate the single-center experience and outcomes of using the Medina Embolic Device (MED) for cerebral aneurysm treatment.
- To assess the safety, efficacy, and angiographic results of the MED.
Main Methods:
- Retrospective analysis of prospectively collected data from 13 patients with 14 cerebral aneurysms treated with the MED.
- Evaluation included angiographic appearance, clinical status, complications, and need for repeat treatment.
Main Results:
- The Medina Embolic Device (MED) demonstrated satisfactory immediate and follow-up angiographic results, with improved occlusion rates when multiple devices were used (75% complete occlusion at 6 months).
- Temporary complications occurred in three patients, with no reported deaths.
- Four patients required repeat treatment, and one pending further intervention.
Conclusions:
- The Medina Embolic Device (MED) is a viable intra-saccular flow-diverting device for cerebral aneurysms, offering an acceptable safety profile.
- The use of a single MED is not advised; further long-term studies are required before widespread adoption.
